|

203Pb-RMX-VHPIB injection Clinical Trials

1 actively recruiting trial across 1 location

No change since August 2026

Also known as: Radiotracer Injection

Pipeline

Phase 1: 1

Top Sponsors

  • Radiomedix, Inc.1

Indications

  • Glioblastoma Multiforme (GBM)1
  • Pancreatic Ductal Adenocarcinoma (PDAC)1
  • Cancer1

Houston, Texas1 trial

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Excel Diagnostics & Nuclear Oncology Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.